Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael

TMFSaintCroix

Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles

GettyImages-1206597318

Emergent BioSolutions Will Manufacture AstraZeneca's COVID-19 Vaccine Candidate

The agreement is valued at approximately $87 million.


GettyImages-458341935

Sanofi and Denali Halt Clinical Trials of Alzheimer Drug

The companies are shifting their joint efforts from DNL747 to DNL788, which has stronger preclinical data.


g.foolcdn

3 International Stocks Whose Products You Will Soon Use

Afterpay, Sea Limited, and Blue Prism might be foreign names to a lot of Americans, but these high-growth stocks are bringing products to our country right now.


GettyImages-1154035422

Is Hasbro Stock a Buy?

In the short term, maybe, but it's doubtful this stock will beat the market long term.


GettyImages-1127763296

Buy Alert: Novavax Stock Is Heading Higher

Speculators are buying up shares of Novavax, based on a vast market opportunity for its COVID-19 vaccine. But there's even better news that largely mitigates any downside risk.

Alnylam_Corporate_Logo

Is Alnylam Pharmaceuticals a Buy?

The stock is up an amazing 2,100% since the company went public, stomping the S&P 500.


GettyImages-518546769

Luckin Coffee Starts Trading Again

The embattled coffee chain in China tries to recover from insider fraud.


GettyImages-1153657403

2 Top E-Commerce Stocks To Buy in May

Carvana and Sea Limited will dominate internet retail for years to come.


GettyImages-1194077002

Disrupter Alert: These 2 Companies Are Changing Healthcare As We Know It

Teladoc Health and Livongo Health are using the internet to make our healthcare faster, cheaper, and smarter.


GettyImages-450806655

Livongo Health Is Making Money

The stock rose sharply on Thursday after the virtual healthcare specialist beat estimates and unexpectedly achieved profitability in the first quarter.

GettyImages-1125105809

Adaptive Biotechnologies and Microsoft Announce New Study of COVID-19 Immune Response

The "ImmuneRace" study will genetically map the T-cells of 1,000 people who have been exposed to SARS-CoV-19.


GettyImages-1201549319

FDA Authorizes Roche's Coronavirus Antibody Test

The new diagnostic tool measures whether a person has developed antibodies for SARS-CoV-2.


GettyImages-800433994

2 Small-Cap Stocks With Big-Cap Potential

Here's why Park Hotels & Resorts and Virgin Galactic are strong buys right now.


GettyImages-1154936786

3 Dirt-Cheap Stocks That Are an Eye-Popping Bargain

Some high-growth names in the beauty and fashion industries are trading at a discount.


FDA Approves Immunomedics' Breast Cancer Drug

Trodelvy is the first treatment approved specifically for triple-negative breast cancer.

GettyImages-1124737544

Is Beyond Meat Stock a Buy?

The stock is up in 2020, beating the market. But a COVID-19 crash might be on the way.


GettyImages-FerrisWheel

Disney to Stop Paying 100,000 Employees

The company is trying to save money while its theme parks are closed.


GettyImages-1015828796

3 Stocks I'm Buying Right Now

In the midst of a global market meltdown, I'm buying virtual companies that are winning market share.


GettyImages-104187467

Where Will AMC Be in a Year?

Bottom fishers beware!


GettyImages-1212665265

Why Is Everyone Talking About OPKO Health Stock?

The pharmaceutical and diagnostics specialist ran into some SEC-related controversy in 2018; now, it's a major player in the fight against COVID-19.